Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
-2493
¥ millionWording
Conditional
How definitive the wording is.Results for this period
Third quarter2024年10月1日〜2025年6月30日ConsolidatedJapanese GAAPNet Sales36,364¥ millionYear on year +18.4%Progress 74.1%
Operating profit4,697¥ millionYear on year -42.4%Progress 77.0%
Ordinary income4,838¥ millionYear on year -40.6%Progress 76.8%
Net income attributable to owners of the parent2,998¥ millionYear on year -47.8%Progress 83.3%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share30.73円
Financial position at period-end
Total assets82,640¥ million
of which net assets 35,475 ¥ millionEquity ratio 42.9%vs. prior year-end -3.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥49,100 million (YoY +15.6%)
Operating profit¥6,100 million (YoY -42.5%)
Ordinary income¥6,300 million (YoY -40.3%)
Net income¥3,600 million (YoY -51.6%)
Revision to Earnings ForecastNet Sales ¥53,647 million → ¥49,100 million（-8.5%） / Operating profit ¥8,627 million → ¥6,100 million（-29.3%） / Ordinary income ¥8,265 million → ¥6,300 million（-23.8%） / Net income ¥5,804 million → ¥3,600 million（-38.0%）
Annual Dividend Forecast¥4 → ¥4（0.0%）
Factors Behind Changes in Business Performance
医心館事業で23事業所を新設し、1事業所を増床したことなどで売上高は増加した。一方、特別調査委員会の調査協力への対応により、新規拠点の入居調整や訪問看護・訪問介護等の売上が当初想定に未達となった。
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 1 / Company name 株式会社ミドリ / Excluded Number of companies 0 / Company name Not disclosed
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Special investigation expenses and related costs ¥199 million, 特別調査費用引当金繰入額 ¥354 million
Depreciation and amortization¥1,974 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End98,112,000
Treasury Shares at Period-End576,604
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2024年10月1日〜2025年6月30日 |
| Net Sales | ¥36,364 million (YoY +18.4%) |
| Operating profit | ¥4,697 million (YoY -42.4%) |
| Ordinary income | ¥4,838 million (YoY -40.6%) |
| Profit attributable to owners of the parent | ¥2,998 million (YoY -47.8%) |
| Net income per share | 30.73円 |
| Equity ratio | End of the current fiscal period 42.9 / End of previous period 46.3 |
| Total assets | ¥82,640 million |
| Net assets | ¥35,475 million |
| Full-year earnings forecast | Net Sales ¥49,100 million (YoY +15.6%) / Operating profit ¥6,100 million (YoY -42.5%) / Ordinary income ¥6,300 million (YoY -40.3%) / Net income ¥3,600 million (YoY -51.6%) |
| Revision to Earnings Forecast | Net Sales ¥53,647 million → ¥49,100 million（-8.5%） / Operating profit ¥8,627 million → ¥6,100 million（-29.3%） / Ordinary income ¥8,265 million → ¥6,300 million（-23.8%） / Net income ¥5,804 million → ¥3,600 million（-38.0%） |
| Annual Dividend Forecast | ¥4 → ¥4（0.0%） |
| Depreciation and amortization | ¥1,974 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Special investigation expenses and related costs ¥199 million, 特別調査費用引当金繰入額 ¥354 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社ミドリ / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 98,112,000 |
| Treasury Shares at Period-End | 576,604 |
| Factors Behind Changes in Business Performance | 医心館事業で23事業所を新設し、1事業所を増床したことなどで売上高は増加した。一方、特別調査委員会の調査協力への対応により、新規拠点の入居調整や訪問看護・訪問介護等の売上が当初想定に未達となった。 |
Items this document does not state (13)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.下半期に拠点職員および本社職員の相当数が通常業務を離れ、特別調査委員会の調査協力に対応した影響で、特に新規拠点の入居調整や訪問看護・訪問介護等の売上が当初想定に未達となったため。稼働率と連動した採用の調整等で費用をコントロールしたものの、営業利益も当初予想を下回る見通しとなった。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.